SORLA controls insulin signaling to promote obesity in mice

Large-scale genetic studies have linked variations in genes and proteins to an increased risk for developing obesity. Determining how these variations alter metabolism to increase body mass may lead to the identification of preventative therapies for obesity and related disorders.

In this month's issue of the JCI, research led by Thomas Willnow at the Max Delbrück Center examined how is controlled by differences in the availability of SORLA, a protein that has been identified as an risk factor for both obesity and Alzheimer's disease.

Increasing SORLA levels led to decreased turnover of fat molecules and increased fat accumulation and in mice. In contrast, reducing SORLA levels protected mice against diet-induced obesity.

Finally, the study determined that SORLA's effects on fat metabolism and were due to its ability to regulate insulin signaling.

This work identifies a mechanism for SORLA's association with obesity risk, and suggests that these metabolic changes could also underlie the link between SORLA and the risk for Alzheimer's disease.

Explore further

Loss of inflammatory signaling molecule protects mice against diet-induced obesity

More information: Vanessa Schmidt et al, SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity, Journal of Clinical Investigation (2016). DOI: 10.1172/JCI84708
Citation: SORLA controls insulin signaling to promote obesity in mice (2016, June 20) retrieved 27 October 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments